Port connector and drug injection device comprising same

The port connector system with flow paths for drug transfer addresses the need for adaptability in insulin injectors, enhancing user convenience and stability by enabling efficient drug delivery and easy configuration updates.

WO2024237546A1PCT designated stage expired Publication Date: 2024-11-21CAREMEDI CO LTD +1
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/006146
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-16
Filing Date
2024-05-08
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Insulin injectors require a flexible configuration to adapt to changes in drug storage and delivery systems, posing challenges in manufacturing and user convenience due to the need for frequent updates and miniaturization.

Method used

A port connector system that includes a main body with first and second flow paths for drug transfer between the drug storage unit, pump assembly, and injection assembly, allowing for electrochemical pressure generation and drug injection, enhancing the versatility of the device.

Benefits of technology

The port connector system enables a thinner, lighter, and more versatile drug injection device that can easily adapt to changes in configuration, improving user convenience and stability of attachment to the skin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024006146_21112024_PF_FP_ABST
    Figure KR2024006146_21112024_PF_FP_ABST
Patent Text Reader

Abstract

A drug injection device, according to the present invention, comprises: a housing which comprises a cover part and a contact surface, and has a mounting space formed between the cover part and the contact surface; a drug storage unit which is disposed in the mounting space and has a drug stored therein; a pump assembly which suctions and discharges the drug from the drug storage unit by electrochemically generating positive pressure and negative pressure; a port connector which is disposed between the drug storage unit and the pump assembly so as to be coupled to the drug storage unit and the pump assembly, and provides a first flow path through which the drug suctioned from the drug storage unit and into the pump assembly moves, and a second flow path through which the drug discharged from the pump assembly moves; and an insertion tube which is coupled to the port connector and injects the drug into a user.
Need to check novelty before this filing date? Find Prior Art

Description

Port connector and drug delivery device including the same

[0001] The present invention relates to a port connector and a drug injection device including the same.

[0002] Depending on the type, purpose, and method of treatment, medications can be administered orally, subcutaneously, or intravenously. Drug infusion devices utilizing drug pumps can automatically inject medication into the body at the desired rate and dose at the required time. Therefore, drug infusion devices utilizing drug pumps can be utilized in a variety of ways, not just in hospitals or patients' daily lives.

[0003] An insulin pump, commonly called an insulin injector, is a medical device that acts like a pancreas to control blood sugar levels by supplying insulin from outside the body at a set time precisely for diabetic patients who do not secrete insulin or secrete only a small amount.

[0004] These insulin pumps are used by patients with insulin-dependent diabetes, and can deliver medication continuously 24 hours a day while attached to the patient. Because insulin injectors require patients to administer medication periodically over long periods of time, active technology development is underway to miniaturize and automate insulin injectors for greater user convenience.

[0005] As technologies for miniaturization and automation of insulin injectors advance, their internal configurations may change, but it is difficult to manufacture the entire assembly to replace it each time a specific configuration changes.

[0006] Therefore, a device that can flexibly respond to changes in specific configurations is required.

[0007] In order to solve the above-mentioned problems, the present invention has as a technical problem a port connector that is coupled with a drug storage unit and a pump assembly.

[0008] In addition, the present invention has as a technical object to provide a drug injection device having a drug storage unit, a pump assembly, and a port connector coupled to an injection assembly in order to solve the above-mentioned problem.

[0009] However, the technical tasks that this embodiment seeks to accomplish are not limited to the technical tasks described above, and other technical tasks may exist.

[0010] As a technical means for solving the above-described technical problem, a port connector according to the present invention comprises: a main body coupled between the drug storage unit and the pump assembly; and a first channel and a second channel formed inside the main body and through which a drug moves, wherein the first channel is a channel through which the drug moves from the drug storage unit toward the pump assembly, and the second channel is a channel through which the drug discharged from the pump assembly moves.

[0011] In addition, a drug injection device according to one embodiment of the present invention includes a housing including a cover part and a contact surface, and a mounting space formed between the cover part and the contact surface; a drug storage part disposed in the mounting space, in which a drug is stored; a pump assembly electrochemically generating positive and negative pressures to draw in and discharge a drug from the drug storage part; a port connector disposed between the drug storage part and the pump assembly, coupled with the drug storage part and the pump assembly, and providing a first path through which the drug drawn from the drug storage part to the pump assembly moves and a second path through which the drug discharged from the pump assembly moves; and an insertion tube coupled with the port connector, for injecting the drug into a user.

[0012] According to the above-described problem-solving means of the present invention, the versatility of the electroosmotic pump can be increased by a port connector that acts as a medium for transferring drugs between the electroosmotic pump and other components.

[0013] FIG. 1 is a front perspective view of a drug injection device according to one embodiment of the present invention.

[0014] FIG. 2 is a rear perspective view of a drug injection device according to one embodiment of the present invention.

[0015] Figure 3 is an internal plan view of the housing illustrated in Figure 1.

[0016] Figure 4 is a plan view of the drug storage unit illustrated in Figure 3.

[0017] Figure 5 is a plan view of the pump assembly illustrated in Figure 3.

[0018] Figure 6 is a block diagram schematically showing the configuration of the pump assembly illustrated in Figure 5.

[0019] Fig. 7 is a block diagram schematically showing the configuration of the driving unit illustrated in Fig. 6.

[0020] Fig. 8 is an exemplary diagram schematically showing the operation of the driving unit illustrated in Fig. 7.

[0021] Figure 9 is a perspective view showing the combined structure of the drug storage unit, pump assembly, and port connector illustrated in Figure 3.

[0022] Figure 10 is a front perspective view of the port connector illustrated in Figure 3.

[0023] Fig. 11 is a cross-sectional view taken along the cutting line A-A' shown in Fig. 10.

[0024] Figure 12 is a rear perspective view of the port connector illustrated in Figure 3.

[0025] Fig. 13 is a cross-sectional view taken along the cutting line B-B' shown in Fig. 12.

[0026] Hereinafter, the present invention will be described in detail with reference to the attached drawings. However, the present invention can be implemented in various different forms and is not limited to the embodiments described herein. In addition, the attached drawings are only intended to facilitate easy understanding of the embodiments disclosed in the present specification, and the technical ideas disclosed in the present specification are not limited by the attached drawings. In order to clearly explain the present invention in the drawings, parts that are not related to the description are omitted, and the size, shape, and shape of each component shown in the drawings can be variously modified. The same / similar drawing reference numerals are assigned to the same / similar parts throughout the specification.

[0027] The suffixes "assembly" and "part" used in the following description for components are assigned or used interchangeably solely for the convenience of writing the specification, and do not in themselves have distinct meanings or roles. Furthermore, in describing the embodiments disclosed herein, detailed descriptions of related known technologies have been omitted if they are deemed to obscure the gist of the embodiments disclosed herein.

[0028] Throughout the specification, when a part is said to be "connected (connected, in contact with, or coupled)" to another part, this includes not only cases where it is "directly connected (connected, in contact with, or coupled)" but also cases where it is "indirectly connected (connected, in contact with, or coupled)" with another member in between. Furthermore, when a part is said to "include (have or provide)" a certain component, this does not mean that it excludes other components, but rather that it may "include (have or provide)" other components, unless otherwise specifically stated.

[0029] As used herein, ordinal terms such as "first," "second," etc., are used solely to distinguish one component from another and do not limit the order or relationship of the components. For example, the first component of the present invention may be referred to as the "second component," and similarly, the second component may also be referred to as the "first component."

[0030] FIG. 1 is a front perspective view of a drug injection device according to an embodiment of the present invention, FIG. 2 is a rear perspective view of a drug injection device according to an embodiment of the present invention, and FIG. 3 is an internal plan view of the housing illustrated in FIG. 1.

[0031] Referring to FIGS. 1 to 3, a patch-type drug injection device (100) according to one embodiment of the present invention will be described. The patch-type drug injection pump (100) includes a housing (110) and components arranged inside the housing (110).

[0032] The housing (110) includes a cover portion (111) and a contact surface (112), and a mounting space is formed between the cover portion (111) and the contact surface (112). The cover portion (111) has rounded corners, so that the patch-type drug injection device (100) can be continuously attached to the injection target without a foreign body sensation. The contact surface (112) is configured to be attached to the injection target, and an outlet (112a) for withdrawing the insertion tube to the outside is formed.

[0033] The mounting space is divided into a central region (113) and first to third regions (114, 115, 116), and the first to third regions (114, 115, 116) are formed in a shape that surrounds the central region (113). In particular, the mounting space within the housing (110) is divided into first to third regions (114, 115, 116) that extend in a direction perpendicular to the insertion direction of the insertion tube, and the central region (113). Then, major components are combined in each region. In a typical case, the PCB circuit part is first arranged over the entire or most of the plane of the device, and then the drug storage part or pump, etc. are arranged on top of it, so there is a problem that the thickness of the device is formed thick. However, in order to make the patch-type drug injection device (100) of the present invention thin, the area where each component overlaps with each other is minimized.

[0034] The components include a drug storage unit (120), a pump assembly (130), a port connector (140), an injection assembly (150), and a circuit unit (160), and can be arranged in the central region (113) and the first to third regions (114, 115, 116) described above. For example, the drug storage unit (120) can be arranged in the first region (114), the pump assembly (130) and the port connector (140) can be arranged in the second region (115), the circuit unit (160) can be arranged in the third region (116), and the injection assembly (150) can be arranged in the central region (113), so that the drug storage unit (120), the pump assembly (130), the port connector (140), and the circuit unit (160) can be arranged in a form that surrounds the injection assembly (150).

[0035] Fig. 4 is a plan view of the drug storage unit illustrated in Fig. 3. Referring to Fig. 4, the drug storage unit (120) stores a drug to be injected, and its thickness varies depending on the amount of drug to be injected. The drug storage unit (120) may be provided as a flat pouch bag made of a polymer material. A closing unit (121) may be formed around the drug storage unit (120) by joining two sides of the drug storage unit (120) to a predetermined width. The closing unit (121) may limit the drug storage unit (120) from expanding toward the drug periphery.

[0036] The drug storage unit (120) may be composed of a polymer film, etc., and the inside and outside of the drug storage unit (120) are made of materials having different melting temperatures, and the melting temperature of the inside material is formed lower than the melting temperature of the outside material. The drug storage unit (120) is made by applying heat to a predetermined temperature at which the inside material melts to form a closing unit (121). When heat is applied to the side of the closing unit (121), the inside materials are attached to each other and finished, and when the lower side is folded into a W shape and heat is applied, the inside materials are attached to each other and the outside materials are not attached to each other, so the patch-type drug injection device (100) is finished in a wrinkled shape. Unlike conventional technologies, since the drug storage unit (120) is formed thinly using a flexible material, the patch-type drug injection device (100) can be implemented to be thinner and lighter.

[0037] In addition, the drug storage unit (120) is coupled with a drug entrance (122) through which drugs are introduced, so that drugs are introduced into the drug storage unit (120) or drugs stored in the drug storage unit (120) are discharged to the outside.

[0038] FIG. 5 is a plan view of the pump assembly illustrated in FIG. 3, FIG. 6 is a block diagram schematically showing the configuration of the pump assembly illustrated in FIG. 5, FIG. 7 is a block diagram schematically showing the configuration of the driving unit illustrated in FIG. 6, and FIG. 8 is an exemplary diagram schematically showing the operation of the driving unit illustrated in FIG. 7.

[0039] The pump assembly (130) will be described in detail with reference to FIGS. 5 to 8.

[0040] Referring to FIGS. 5 and 6, the pump assembly (130) is an electrochemically driven pump and includes a driving unit (131), a transport chamber (132), a suction unit (133), and a discharge unit (134). The driving unit (131) is electrochemically driven by a control signal to generate positive and negative pressures, thereby drawing in a drug from a drug storage unit (120), storing it in a transport chamber (132), and discharging the drug stored in the transport chamber (132) to an injection assembly (150). The transport chamber (132) receives the drug drawn from the drug storage unit (120) by the driving unit (131). In addition, the suction unit (133) transfers the drug from the drug storage unit (120) to the transport chamber (132), and the discharge unit (134) discharges the drug from the transport chamber (132) to the insertion tube (151) of the injection assembly (150). Here, the drug is a drug that must be injected into a specific patient, such as insulin injected into a diabetic patient.

[0041] Referring to FIGS. 7 and 8, the driving unit (131) is specifically described. The driving unit (131) is a pump that uses the movement of fluid by the electroosmotic phenomenon that occurs when voltage or current is applied using electrodes at both ends of a pressure generating unit (membrane, 131a). The driving unit (131) may include a power source (131d) that applies voltage or current to a membrane (131a) and a first electrode (131b) and a second electrode (131c) arranged on both sides of the membrane (131a), a first diaphragm (131e) for moving the fluid, and a second diaphragm (131f). Each diaphragm (131e, 131f) is provided on one side and the other side of the membrane (131a) and changes shape by the movement of the pumping solution as positive pressure and negative pressure are alternately generated. For example, the first diaphragm (131e) and the second diaphragm (131f) transfer the negative pressure and positive pressure generated by the driving of the membrane (131a) to the fluid to be transported. More specifically, when negative pressure is generated, at least a part of the first diaphragm (131e) and the second diaphragm (131f) moves backward (when moving in the ① direction), and the fluid to be transported is sucked into the transport chamber (132). Conversely, when positive pressure is generated, at least a part of the first diaphragm (131e) and the second diaphragm (131f) moves forward (when moving in the ② direction), and the fluid to be transported is discharged from the transport chamber (132).

[0042] The materials used for the membrane (131a) are generally silica, glass, etc., and when these are immersed in an aqueous solution, their surfaces become negatively charged. The membrane (131a) has numerous paths through which fluids can pass, and when one of these is enlarged, the surface of the fluid passage with a negative charge (bound anion) can be in a state where the charge is balanced by cations (mobile cations) with a movable (+) charge. In this state, when a (+) voltage is applied to the first electrode (131b) and a (-) voltage is applied to the second electrode (131c), a negative pressure is generated, and the fluid inside the driving unit (131) moves in direction ① due to this negative pressure. At this time, the drug is inhaled through the suction path (133b) and flows into the transport chamber (132) through the first check valve (133a). At this time, the second check valve (134a) is closed to prevent negative pressure from being transmitted to the discharge path (134b). Conversely, when a (-) voltage is applied to the first electrode (131b) and a (+) voltage is applied to the second electrode (131c), a positive pressure in the opposite direction is generated by a reversible electrochemical reaction. The fluid inside the driving unit (131) moves in direction ② due to this positive pressure. At this time, the drug stored in the transport chamber (132) is injected into the subject through the discharge path (134b) via the second check valve (134a). At this time, the first check valve (133a) is closed to prevent positive pressure from being transmitted to the suction path (133b).

[0043] This phenomenon is called electroosmosis, and a pump utilizing this principle is an electroosmotic pump (110). Since the patch-type drug injection device (100) of the present invention uses a pump assembly (130) as a driving means, it can be manufactured with a thin overall thickness and can be more stably attached to the skin.

[0044] Figure 9 is a perspective view showing the combined structure of the drug storage unit, pump assembly, and port connector illustrated in Figure 3.

[0045] Referring to FIG. 9, a port connector (140) is disposed between the drug storage unit (120) and the pump assembly (130) and is coupled to the drug storage unit (120) and the pump assembly (130), and provides a path through which a drug flowing from the drug storage unit (120) into the pump assembly (130) moves and a path through which a drug discharged from the pump assembly (130) into the insertion tube (151) of the injection assembly (150) moves.

[0046] Fig. 10 is a front perspective view of the port connector illustrated in Fig. 3, and Fig. 11 is a cross-section taken along the cutting line A-A' illustrated in Fig. 10.

[0047] Referring to FIGS. 10 and 11, the port connector (140) is coupled with the drug storage unit (120), the pump assembly (130), and the insertion tube (151) of the injection assembly (150), and includes a main body (141) having a first flow path (142) and a second flow path (143) formed therein.

[0048] The main body (141) may include a housing (141a), a partition wall (141b), and a support member (141c). The housing (141a) has a predetermined space formed therein, and the partition wall (141b) is disposed inside the housing (141a) to divide the internal space of the housing (141a) into a first space and a second space. A first flow path (142) is disposed in the first space, and a second flow path (143) is disposed in the second space. In addition, the end of the housing (141a) and the end of the partition wall (141b) may be formed to have a predetermined area for sealingly connecting with the end of the pump assembly (130).

[0049] In addition, the support member (141c) connects the housing (141a) and the first euro (142) or the second euro (143), or connects the bulkhead (141b) and the first euro (142) or the second euro (143), thereby fixing the first euro (142) and the second euro (143).

[0050] The first flow path (142) is a flow path through which the drug moves from the drug storage unit (120) to the pump assembly (130), and the second flow path (143) is a flow path through which the drug moves from the pump assembly (130) to the insertion tube (151).

[0051] Here, the first flow path (142) and the second flow path (143) can be formed in a cylindrical shape, and the length of the first flow path (142) can be formed longer than the length of the second flow path (143). The first flow path (142) and the second flow path (143) are formed parallel to each other inside the main body (141), and can have a shape as in FIG. 11 due to the difference in length between the first flow path (142) and the second flow path (143). The drug injection device (100) of the present invention can increase space utilization by arranging the injection assembly (150) for injecting the drug to the user on the lower side of the second flow path (143) of the port connector (140) as shown in FIG. 4 due to the shape of the port connector (140), and thereby can minimize the size, thereby reducing user inconvenience.

[0052] In addition, the first flow path (142) has one end connected to the drug storage unit (120) and the other end connected to the pump assembly (130), and the second flow path (143) has one end connected to the injection assembly (150) and the other end connected to the pump assembly (130). To have this connection structure, the main body (141) includes first to fourth coupling grooves (144, 145, 146, 147). The first coupling groove (144) is formed on one side of the first flow path (142) so that the drug inlet (122) of the drug storage unit (120) is inserted and coupled thereto, and the second coupling groove (145) is formed on the other side of the first flow path (142) so that the suction unit (133) of the pump assembly (130) is inserted and coupled thereto. The third coupling groove (146) is formed on one side of the second passage (143) to couple the insertion tube (151) of the injection assembly (150), and the fourth coupling groove (147) is formed on the other side of the second passage (143) to couple the discharge portion (134) of the pump assembly (130) to be inserted and coupled. Here, the third coupling groove (146) may further include a sealing member (not shown) that seals the coupling portion with the insertion tube (151).

[0053] Fig. 12 is a rear perspective view of the port connector, and Fig. 13 is a cross-sectional view taken along the cutting line B-B' shown in Fig. 12.

[0054] Referring to FIGS. 12 and 13, the port connector (140) may further include a drug injection path (148) in the main body (141). The drug injection path (148) is formed in a direction intersecting the direction in which the first flow path (142) advances, has one end connected to the first flow path (142), and has the other end open to the outside. The drug injection path (148) is a path through which a drug can be injected into the first flow path (142) using a drug injection syringe, and is used when filling the drug storage unit (120) with the drug at the beginning of the operation of the drug injection device (100) of the present invention.

[0055] In this way, the port connector (140) can serve as a medium for transferring drugs between the drug storage unit (120) and the pump assembly (130) and between the pump assembly (130) and the injection assembly (150), thereby increasing the versatility of the pump assembly (130). If the pump assembly (130), the drug storage unit (120), and the injection assembly (150) are directly connected, the structure of the pump assembly (130) must also be changed as the shape of the connection portion of the drug storage unit (120) or the injection assembly (150) changes. However, since the connection portion of the port connector (140) can be changed according to the changed structures of the drug storage unit (120) and the injection assembly (150) while maintaining the structure of the pump assembly (130), the versatility of the pump assembly (130) can be expanded.

[0056] Referring again to FIG. 4, the injection assembly (150) can inject a drug discharged from the pump assembly (130) into a subject of injection by including an insertion tube (151), and the circuit unit (160) has electronic components required for driving and controlling the pump assembly (130) mounted thereon and can include a battery (161) for supplying power.

[0057] Additionally, an additional configuration of a patch-type drug injection device (100) is described with reference to FIGS. 1 and 2.

[0058] Referring to Fig. 1, a shooting hole (111a) is formed in a region corresponding to the region where the injection assembly (150) is placed in the cover portion (111) of the housing (110). The shooting hole (111a) is a hole (111a) into which a shooting member of a shooting device (not shown) that pressurizes the injection assembly (150) is inserted so that the insertion tube (151) can be inserted into the injection target.

[0059] Referring to Fig. 2, a drug injection hole (112b) and an air vent hole (112c) are formed on the contact surface (112) of the housing (110). The drug injection hole (112b) is a hole for supplying a drug to be stored in the drug storage unit (120) from the outside, and the air vent hole (112c) is a hole for removing the pressure difference between the inside and the outside of the housing (110). The drug injection hole (112b) is formed at a position corresponding to a drug injection path (148) formed in the port connector (140), and the drug can be injected through the drug injection hole (112b) and the drug injection path (148) using a syringe or the like.

[0060] In addition, the patch-type drug injection device (100) may include a sound output device (not shown) inside the housing (110) to provide a notification for a specific situation. In addition, the circuit unit (160) may include a sound output circuit unit that can stop the operation of the sound output device (not shown), and a buzzer stop hole (112d) that provides a passage for manipulating the sound output circuit unit of the circuit unit (160) may be formed on the contact surface (112). Here, a silicone cap may be coupled to the discharge port (112a) and the drug injection hole (112b), and an air vent sticker may be attached to the air vent hole (112c) and the buzzer stop hole (112d).

[0061] Those skilled in the art will appreciate that, based on the above description, the present invention can be readily modified into other specific forms without altering the technical spirit or essential characteristics thereof. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive. The scope of the present invention is defined by the following claims, and all changes or modifications derived from the meaning and scope of the claims and their equivalents should be construed as being included within the scope of the present invention.

[0062] The scope of the present invention is indicated by the claims described below rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention.

Claims

1. In a port connector coupled to a pump assembly and a drug storage unit of a drug injection device, a body coupled between the drug storage unit and the pump assembly; and Including a first flow path and a second flow path formed inside the main body and through which the drug moves, The first flow path is a flow path through which the drug moves from the drug storage unit toward the pump assembly, The above second euro is a port connector through which the drug discharged from the pump assembly moves.

2. In paragraph 1, The above first euro and the above second euro are formed parallel, A port connector wherein the length of the second euro is shorter than the length of the first euro.

3. In paragraph 1, The above body, a housing in which a predetermined space is formed; and A partition wall is disposed inside the housing and divides the space into a first space and a second space, A port connector, wherein the first euro is placed in the first space, and the second euro is placed in the second space.

4. In paragraph 3, The first and second euros are each formed in a cylindrical shape, The above body, A port connector further comprising a housing in which the first space and the second space are formed and a support connecting the first or second flow path, or connecting the bulkhead and the first or second flow path.

5. In paragraph 3, A port connector, wherein the end of the housing and the end of the bulkhead are formed to have a predetermined area for sealing connection with the end of the pump assembly.

6. In paragraph 1, The above first euro is, One end is coupled to the drug storage unit, and the other end is coupled to the pump assembly. The above second euro is, A port connector, one end of which is connected to an insertion tube for delivering the drug to the user, and the other end of which is connected to the pump assembly.

7. In paragraph 6, The above body, A first coupling groove formed on one side of the first euro and into which the drug inlet / outlet of the drug storage unit is inserted / coupled; and A port connector comprising a second coupling groove formed on the other side of the first euro and into which the suction portion of the pump assembly is inserted and coupled.

8. In paragraph 6, The above body, A third joining groove formed on one side of the second euro and to which the insertion tube is joined; and It includes a fourth coupling groove formed on the other side of the second euro and into which the discharge portion of the pump assembly is inserted and coupled; A port connector further comprising a sealing member for sealing a joint portion with the insertion tube in the third defect groove.

9. In paragraph 1, The above body, A port connector further comprising a drug injection path formed in a direction intersecting the direction of travel of the first euro.

10. In paragraph 9, With the above drug injection, A port connector, one end of which is connected to the first euro and the other end is open to the outside of the main body.

11. In paragraph 10, The above body, A port connector further comprising a sealing member into which a drug injection syringe is inserted into the drug injection path.

12. In the drug injection device, A housing including a cover portion and a contact surface, and a mounting space formed between the cover portion and the contact surface; A drug storage unit placed in the above-mentioned space and in which drugs are stored; A pump assembly that electrochemically generates positive and negative pressure to suck and discharge a drug from the drug storage compartment; A port connector disposed between the drug storage unit and the pump assembly, coupled to the drug storage unit and the pump assembly, and providing a first path through which the drug drawn from the drug storage unit to the pump assembly moves and a second path through which the drug discharged from the pump assembly moves; and A drug injection device, comprising an insertion tube coupled to the port connector and injecting the drug into the user.

13. In paragraph 12, The above port connector is, A main body coupled with the drug storage unit, the pump assembly and the insertion tube, and having the first flow path and the second flow path formed therein, The first flow path is a flow path through which the drug moves from the drug storage unit to the pump assembly, A drug injection device, wherein the second flow path is a flow path through which the drug moves from the pump assembly to the injection assembly.

14. In paragraph 13, The above first euro and the above second euro are formed parallel, A drug injection device, wherein the length of the second euro is shorter than the length of the first euro.

15. In paragraph 13, The above body, The above body, a housing having a predetermined space formed therein; and A partition wall is disposed inside the housing and divides the space into a first space and a second space, A drug injection device, wherein the first euro is placed in the first space, and the second euro is placed in the second space.

16. In paragraph 15, The first and second euros are each formed in a cylindrical shape, The above body, A drug injection device further comprising a housing in which the first space and the second space are formed and a support connecting the first flow path or the second flow path, or connecting the partition wall and the first flow path or the second flow path.

17. In paragraph 15, A drug injection device, wherein the end of the housing and the end of the bulkhead are formed to have a predetermined area for sealing connection with the end of the pump assembly.

18. In paragraph 12, The above pump assembly, A driving unit that generates positive and negative pressures alternately electrochemically; A transport chamber frame coupled to one side of the above driving unit and having a transport chamber formed therein to accommodate the drug; and A fluid transport device comprising a suction unit and a discharge unit coupled to one side of the transport chamber frame and connected to the transport chamber.

19. In paragraph 18, The above body, A first coupling groove formed on one side of the first euro and into which the drug inlet / outlet of the drug storage unit is inserted / coupled; and A drug injection device comprising a second coupling groove formed on the other side of the first euro and into which the suction unit is inserted and coupled.

20. In paragraph 19, The above body, A third joining groove formed on one side of the second euro and into which the insertion tube of the injection assembly is joined; and It includes a fourth joining groove formed on the other side of the second euro and into which the discharge part is inserted and joined, A drug injection device further comprising a sealing member for sealing a joint portion with the insertion tube in the third defect groove.

21. In paragraph 13, The above body, A drug injection device further comprising a drug injection path formed in a direction intersecting the direction of travel of the first euro.

22. In paragraph 21, With the above drug injection, A drug injection device, one end of which is connected to the first euro and the other end is open to the outside of the main body.

23. In paragraph 22, The above body, A drug injection device further comprising a sealing member into which a drug injection syringe is inserted into the drug injection path.

Citation Information

Patent Citations

  • Connection member, pump casing and injection device comprising connection member and liquid confirmation method using connection member

    JP2020039610A

  • Cartridge mode medicine injection device

    KR101347640B1

  • Apparatus for micro-dialysis of interstitial fluid using electroosmotic pump and operating method thereof

    KR101979385B1

  • Portable fluid delivery system

    KR1020160021194A

  • Electoosmotic pump

    KR1020180024990A